Phase 4 Transgender Clinical Trials
7 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–7 of 7 trials
Recruiting
Phase 4
Investigating Gender and Sex Differences in Immune Responses Through Vaccination of Transgender and Cisgender Persons
VaccinationTransgender PersonsMeningococcal Meningitis, Serogroup B+1 more
University Ghent250 enrolled1 locationNCT06832514
Recruiting
Phase 4
Androgen Effects on the Reproductive Neuroendocrine Axis, 2025 Version
Reproductive IssuesTransgenderism
University of California, San Diego80 enrolled1 locationNCT07092527
Not Yet Recruiting
Phase 4
Low-dose testosterone treatment in trans individuals
Transgender healthDepressionSuicide
University of Melbourne48 enrolled1 locationACTRN12624001337561
Completed
Phase 4
Testosterone for gender dysphoria in transgender men
Transgender healthDepressionSuicide
University of Melbourne74 enrolled1 locationACTRN12621000716864
Withdrawn
Phase 4
A randomised placebo-controlled trial of low-dose transdermal estrogen in transgender women during surgery
Gender affirmation surgeryThrombosisTransgender
University of Melbourne32 enrolled1 locationACTRN12621000022864
Not Yet Recruiting
Phase 4
Micronised progesterone for sleep in transgender women
Transgender healthAnxiety
Austin Health38 enrolled1 locationACTRN12620001364965
Not Yet Recruiting
Phase 4
Progesterone for transgender women
SleepAnxietyTransgender
Austin Health38 enrolled1 locationACTRN12620001130954